Bullish option flow detected in Cytokinetics with 5,743 calls trading, 1.7x expected, and implied vol increasing almost 11 points to 95.73%. Jan-24 75 calls and 1/12 weekly 90 calls are the most active options, with total volume in those strikes near 1,700 contracts. The Put/Call Ratio is 0.37. Earnings are expected on February 28th.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CYTK:
- Edgewise shares still reflect limited credit for EDG-7500, says Wedbush
- Cytokinetics price target raised to $86 from $60 at Truist
- Cytokinetics price target raised to $85 from $41 at BofA
- JPMorgan sees Cytokinetics shares working into 2024 after data
- Cytokinetics price target raised to $100 from $58 at Barclays
